Pfizer Stock Sinks To 10-Year Low Why Investors Have Soured On Covid-Era Giant
This stock isn’t one to buy on the pullback for investors with a short-term focus. For those with a long-term perspective who are seeking juicy dividends, however, buying Pfizer after today’s sell-off could be a smart move. The pharma giant also projects adjusted diluted earnings per share (EPS) of between $2.05 and $2.25 in 2024, …
Pfizer Stock Sinks To 10-Year Low Why Investors Have Soured On Covid-Era Giant Read More »